Curriculum vitae

Main Research Areas
  • Tumour and infection immunology
  • Epidemiology of infections of  von Infektionen immunosuppressed patients
  • Clinical diagnostic and therapeutical studies
Professional Career
2014 Deputy head of the Nationales Referenzzentrum für invasive Pilzinfektionen
2013 W2-professorship in infection research in haematology and oncology, medical faculty, Friedrich-Schiller University Jena
2010 Habilitation in internal medicine, Rheinische Friedrich-Wilhelms University Bonn
2008-2013 Senior physician in the dept. haematology / oncology (med. clinic III), University Hospital, Bonn
2007-2008 EBMT Fellowship Bone Marrow Transplantation Programme, Leeds, UK
2007 Acceptance of the priority area haematology / oncology
2006 Specialist in internal diseases
2003-2004 Gerok fellowship within the BonFor funding programme, medical faculty Bonn
1999-2007 Doctor in practical training (AiP) /assistant physician in internal medicine, University Hospital Bonn
1999 PhD in clinical pharmacology, „magna cum laude“, medical faculty, Rheinische Friedrich-Wilhelms University Bonn
1998 Staatsexamen (state examination) human medicine
Awards · Appointments · Scientific Activities
Since 2013 Member of the ethics commission, medical faculty of the FSU Jena
Since 2013 Board member of the working group dealing with infections in haematology and oncology (AGIHO) of the Deutsche Gesellschaft für Hämatologie und internistische Onkologie (DGHO)
Since 2008 Member of the AGIHO
2008-2010 Assistant lecturer at the medical clinic III of the University Hospital Bonn
2002-2006 Member of the statutes commission of the medical faculty of the Rheinische Friedrich-Wilhelms University Bonn
2009 Best abstract DGHO
2008 Poster award
Since 2004 Assessor of several magazines

Publications

von Lilienfeld-Toal M (2020) Community-acquired respiratory viruses in oncology: Lessons to be learnt from the SARS-CoV-2 pandemic. Oncol Res Treat 43(6), 262-263.
von Lilienfeld-Toal M, Vehreschild JJ, Cornely O, Pagano L, Compagno F, Hirsch HH (2020) Frequently asked questions regarding SARS-CoV-2 in cancer patients-recommendations for clinicians caring for patients with malignant diseases. Leukemia 34(6), 1487-1494. (Review)
Brioli A, Klaus M, Sayer H, Scholl S, Ernst T, Hilgendorf I, Scherag A, Yomade O, Schilling K, Hochhaus A, Mügge LO, von Lilienfeld-Toal M (2019) The risk of infections in multiple myeloma before and after the advent of novel agents: a 12-year survey. Ann Hematol 98(3), 713-722.
Dimitriou V, Biehl LM, Hamprecht A, Vogel W, Dörfel D, Peter S, Schafhausen P, Rohde H, von Lilienfeld-Toal M, Klassert TE, Slickers P, Ehricht R, Slevogt H, Christ H, Hellmich M, Farowski F, Tsakmaklis A, Higgins PG, Seifert H, Vehreschild MJGT (2019) Controlling intestinal colonization of high-risk haematology patients with ESBL-producing Enterobacteriaceae: a randomized, placebo-controlled, multicentre, Phase II trial (CLEAR). J Antimicrob Chemother 74(7), 2065-2074.
Hartung S, Rauh C, Boettcher S, Hoang MTN, Jahreis S, Rummler S, Hochhaus A, von Lilienfeld-Toal M (2019) Measuring phagocytosis of Aspergillus fumigatus conidia by human leukocytes using flow cytometry. J Vis Exp (154),
Hartung S, Rauh C, Hoang TNM, Jahreis S, Wagner K, Macheleidt J, Brakhage AA, Rummler S, Hochhaus A, von Lilienfeld-Toal M (2019) Fast and quantitative evaluation of human leukocyte interaction with Aspergillus fumigatus conidia by flow cytometry. Cytometry A 95(3), 332-338.
Hütter-Krönke ML, Fiedler W, Kündgen A, Krauter J, von Lilienfeld-Toal M, Döhner H, Schlenk RF (2019) Continuous high dosing of lenalidomide in relapsed, refractory or older newly diagnosed acute myeloid leukemia patients not suitable for other treatment options - results from a phase I study. Haematologica 104(2), e63-e64.
Jahreis S, Boettcher S, von Lilienfeld-Toal M (2019) MAIT cell activation by fungal pathogens. Methods Mol Biol 2098, 167-177.
Kochanek M, Schalk E, von Bergwelt-Baildon M, Beutel G, Buchheidt D, Hentrich M, Henze L, Kiehl M, Liebregts T, von Lilienfeld-Toal M, Classen A, Mellinghoff S, Penack O, Piepel C, Böll B (2019) Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol 98(5), 1051-1069.
Roth M, Daas L, Renner-Wilde A, Cvetkova-Fischer N, Saeger M, Herwig-Carl M, Matthaei M, Fekete A, Kakkassery V, Walther G, von Lilienfeld-Toal M, Mertens C, Lenk J, Mehlan J, Fischer C, Fuest M, Kroll S, Bayoudh W, Viestenz A, Frings A, MacKenzie CR, Messmer EM, Seitz B, Kurzai O, Geerling G (2019) Das Deutsche Pilz-Keratitis-Register: Erste Ergebnisse einer multizentrischen Erhebung [The german keratomycosis registry: Initial results of a multicenter survey]. Ophthalmologe 116(10), 957-966.